ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

POLX Polarean Imaging Plc

3.65
-0.10 (-2.67%)
01 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Polarean Imaging Plc LSE:POLX London Ordinary Share GB00BF3DT583 ORD GBP0.00037
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.10 -2.67% 3.65 3.50 3.80 3.75 3.65 3.75 886,965 08:45:57
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Surgical,med Instr,apparatus 1.03M -13.91M -0.0644 -0.57 7.88M
Polarean Imaging Plc is listed in the Surgical,med Instr,apparatus sector of the London Stock Exchange with ticker POLX. The last closing price for Polarean Imaging was 3.75p. Over the last year, Polarean Imaging shares have traded in a share price range of 3.65p to 32.25p.

Polarean Imaging currently has 215,848,593 shares in issue. The market capitalisation of Polarean Imaging is £7.88 million. Polarean Imaging has a price to earnings ratio (PE ratio) of -0.57.

Polarean Imaging Share Discussion Threads

Showing 951 to 972 of 6500 messages
Chat Pages: Latest  44  43  42  41  40  39  38  37  36  35  34  33  Older
DateSubjectAuthorDiscuss
20/5/2021
14:51
Just to let shareholders and prospective investors know that Polarean Imaging plc, ANGLE plc, Inspiration Healthcare Group plc, Diaceutics and IBT will be presenting at Mello Events’ Healthcare webinar on the 25th May at 5:30pm-9:30pm. The webinar will also include the latest insights and analysis from investment managers, research professionals, analysts and experienced investors. If you are a shareholder and you would like a ticket to the Healthcare event, please use the code SHVIP75 to receive 75% off your ticket.
Additionally, on the 24th May, The Property Franchise Group PLC and Samarkand will be presenting at the MELLOMonday webinar event on 24th May at 6pm-9:30pm. There will also be special insights from Michael Taylor (@shiftingshares): Using technical analysis to find trades.
There will be over 600 investors attending and these are very popular shows with company presentations, fund manager and investor interviews, and panel sessions including the popular Mello BASH (Buy, Avoid, Sell or Hold).
If you purchase a ticket to MELLOMonday, you will automatically get sent a link to the healthcare event! Tickets are still available and if you would like one at half price then enter the code MMTADVFN50.

melloteam
19/5/2021
13:46
Small top up
markstevenkirby80
18/5/2021
13:33
Well done and good to see you here.
actybod
18/5/2021
08:37
The 25700 just traded was in fact a buy by me. couldn't believe my luck!
ridicule
14/5/2021
13:09
These are virtual conferences so there will be delegates hooking up from all over the world. In any case the American Thoracic Society virtual conference will surely have primarily an American audience!
mavern
14/5/2021
12:37
LOL, I think you are pretty out of touch with what goes on in the NHS. They are still struggling to get enough MRI and they start at €30K a pop now. There are far better and bigger markets to target than UK in my view. I'm very much hoping that after FDA we are not demand constrained anyway.

I'd love to think the UK was at the cutting edge in medical imaging care but from what I'm told anecdotally they are struggling to get budget for the mainstream stuff.

loglorry1
14/5/2021
12:12
Yes, but if there's a 'Long Term Plan' for the NHS it should be taking account of important new developments in diagnosis and treatment. If the clinicians aren't made aware of the future imaging possibilities, they'll build pathways that don't use them, and then entrenched positions will have to be changed. I think it's important that hospitals start budgeting for hyperpolarised imaging now.
supernumerary
14/5/2021
11:49
That's research not general medicine no? There's quite a bit of medical research going on in the UK using it. I don't think that really means its will extend to general NHS usage alas.
loglorry1
14/5/2021
11:46
log - tell your friend s/he's behind the times:
supernumerary
14/5/2021
11:15
It's in the UK. It's not a POLX market and I very much doubt the NHS would buy even one machine. My friend who works in radiology at a big teaching hospital says that it would be far too cutting edge. POLX is all about tier 1 US hospitals for a good while yet.
loglorry1
14/5/2021
09:35
Conference season
actybod
13/5/2021
23:08
Good reference - might be worth checking with Richard
actybod
13/5/2021
23:04
Mildly surprised there's no Polarean reference here:



Improving lung health in England - priorities for prevention, integrated care delivery, and innovation

This conference will assess the priorities and next steps for improving lung health in England.


The discussion takes place in the context of significant health policy developments, with respiratory disease:

- having been made a clinical priority within the NHS Long Term Plan
- being moved forward by the Health and Care Bill, following reforms proposed in the Government’s recent white paper on the future of health and care, designed to support the development of integrated and preventative healthcare in order to enable the delivery of ambitions in the Plan

It also comes with increased focus on respiratory health more broadly due to the COVID-19 pandemic, the respiratory effects seen in sufferers of long COVID, and on air pollution as a factor in lung health.


We are pleased that keynote speakers include: Sarah Woolnough, Chief Executive, Asthma UK and British Lung Foundation; David Rhodes, Director of Environmental Public Health, Public Health England; Jonathan Fuld, Consultant Physician, Cambridge University Hospitals NHS Foundation Trust; Dr Sundeep Kaul, Consultant in Intensive Care & Respiratory Medicine, The Royal Brompton & Harefield NHS Foundation Trust; and Professor Tom Wilkinson, Professor of Respiratory Medicine, Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton.


The agenda looks at next steps for:

- responding to the pandemic, and the challenges of long COVID
- lung health in the implementation of the NHS Long Term Plan
- optimising respiratory prescribing
- promoting prevention and addressing inequalities, including air quality improvement and developing healthy communities
- integrated respiratory care, rehabilitation and care at a local level
- research, innovation and priorities for service transformation

[...]

supernumerary
12/5/2021
14:45
Richard, as always, comes across as smooth as silk, always tells the story so well, no hype, no supposition but always drops a little clue or two, as he did here, about what he cannot say but you maybe able to discover for yourself. I have to say that JW has exactly the right instincts but he is a complete muppet and so clearly does not understand the technology, how it works or why it really is so revolutionary. That said better to be lucky than good.
40 fathoms
12/5/2021
10:46
Be nice to have a step tbh as I would like a top up
moontheloon
12/5/2021
10:20
It's a psychological barrier, hope we break it, all irrelevant for the movement on fda approval which draws nigh
moontheloon
12/5/2021
08:42
We going to ,100p this week
markstevenkirby80
10/5/2021
11:17
Happy , steady as she blows
markstevenkirby80
10/5/2021
10:33
Possible 100 bagger. Keep hold of your golden tickets.
richardjohn10
10/5/2021
10:21
Very much a vote of confidence this second machine at bc
moontheloon
10/5/2021
10:12
And there goes the first few £ buys
rhatton
10/5/2021
08:12
Looking good in the coming weeks /months,
markstevenkirby80
Chat Pages: Latest  44  43  42  41  40  39  38  37  36  35  34  33  Older

Your Recent History

Delayed Upgrade Clock